Golden has been acquired by ComplyAdvantage.Read about it here ⟶

CuraSen Therapeutics

CuraSen Therapeutics, Inc. is a privately funded biopharmaceutical company pursuing development of novel treatments for neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease, as well as several orphan indications

Overview Structured Data Issues Contributors Activity

curasen.com

Is a

Organization

Company

Company attributes

Industry

Biomedical engineering

Location

B2X

CEO

Founder

Number of Employees (Ranges)

11 – 50

Email Address

info@curasen.com

Full Address

930 Brittan Rd., Ste. 306 San Carlos, CA 94070

CIK Number

1,765,883

Investors

Longitude Capital

Total Funding Amount (USD)

18,000,000

Latest Funding Round Date

November 5, 2021

CTO

‌

Michael D

Patents Assigned (Count)

Country

United States

Other attributes

Company Operating Status

Active

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like CuraSen Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API